ASTRAZENECA PLC |
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
| 141,6 EUR | -0,21% |
|
-1,70% | +15,93% |
Métier
- ventes de produits (95,6%). Le CA par domaine thérapeutique se ventile entre oncologie (39,2%), maladies cardio-vasculaires, rénales et métaboliques (24,2%), maladies respiratoires et auto-immunes (13,9%) et autres (22,7% ; maladies inflammatoires, maladies neurologiques, maladies gastro-intestinales et maladies infectieuses) ;
- revenus de collaboration (4,4%).
La répartition géographique du CA est la suivante : Royaume Uni (7,4%), Europe (21,2%), Amérique (45,3%) et Afrique-Asie-Australie (26,1%).
Nombre d'employés: 89 900
Ventes par activité
| GBP en Millions | 2022 | Poids | 2023 | Poids | Delta |
|---|---|---|---|---|---|
Oncology
37,4
%
| 11 878 | 33,0 % | 13 793 | 37,4 % | +16,12% |
Cardiovascular, Renal and Metabolism
23,1
%
| 7 459 | 20,7 % | 8 515 | 23,1 % | +14,16% |
Rare Disease
16,9
%
| 5 726 | 15,9 % | 6 246 | 16,9 % | +9,08% |
Respiratory and Immunology
13,3
%
| 4 680 | 13,0 % | 4 913 | 13,3 % | +4,97% |
Alliance
3,1
%
| - | - | 1 149 | 3,1 % | - |
Other Medicines
2,6
%
| 1 319 | 3,7 % | 946 | 2,6 % | -28,29% |
Vaccines and Immune Therapies
2,2
%
| 3 845 | 10,7 % | 814 | 2,2 % | -78,83% |
Collaboration
1,3
%
| 1 098 | 3,1 % | 478 | 1,3 % | -56,50% |
Ventes par région
| GBP en Millions | 2022 | Poids | 2023 | Poids | Delta |
|---|---|---|---|---|---|
United States
39,6
%
| 14 027 | 39,0 % | 14 578 | 39,6 % | +3,93% |
China
12,8
%
| 4 662 | 12,9 % | 4 724 | 12,8 % | +1,32% |
Japan
7,9
%
| 3 236 | 9,0 % | 2 928 | 7,9 % | -9,51% |
United Kingdom
7,4
%
| 2 530 | 7,0 % | 2 709 | 7,4 % | +7,07% |
Other Rest of Europe
6,8
%
| 2 197 | 6,1 % | 2 502 | 6,8 % | +13,89% |
Germany
4,6
%
| 1 544 | 4,3 % | 1 689 | 4,6 % | +9,36% |
Other Asia, Africa and Australasia
4,5
%
| 1 953 | 5,4 % | 1 645 | 4,5 % | -15,77% |
Sweden
3,7
%
| 1 397 | 3,9 % | 1 371 | 3,7 % | -1,89% |
Other Americas
3,7
%
| 954 | 2,6 % | 1 354 | 3,7 % | +41,94% |
France
2,5
%
| 899 | 2,5 % | 927 | 2,5 % | +3,12% |
Canada
2,1
%
| 947 | 2,6 % | 778 | 2,1 % | -17,82% |
Spain
1,8
%
| 599 | 1,7 % | 681 | 1,8 % | +13,73% |
Italy
1,8
%
| 597 | 1,7 % | 654 | 1,8 % | +9,61% |
Australia
0,9
%
| 464 | 1,3 % | 314 | 0,9 % | -32,32% |
Dirigeants
| Dirigeants | Titre | Age | Depuis |
|---|---|---|---|
Pascal Soriot
CEO | Chief Executive Officer | 64 | 01/10/12 |
Aradhana Sarin
DFI | Director of Finance/CFO | 50 | 01/08/21 |
Cindy Hoots
CTO | Chief Tech/Sci/R&D Officer | 56 | 01/01/20 |
Sharon Barr
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/23 |
Regina Danielson
CTO | Chief Tech/Sci/R&D Officer | 60 | - |
| Chief Tech/Sci/R&D Officer | - | 18/05/23 | |
Pam Cheng
COO | Chief Operating Officer | 53 | 01/06/15 |
Jeffrey Pott
CMP | Compliance Officer | - | 01/01/95 |
| Corporate Officer/Principal | 63 | 01/01/02 | |
Iskra Reic
PRN | Corporate Officer/Principal | - | 01/01/01 |
Administrateurs
| Administrateurs | Titre | Age | Depuis |
|---|---|---|---|
Sherilyn McCoy
BRD | Director/Board Member | 65 | 01/10/17 |
Ahmed Hamdy
PRN | Corporate Officer/Principal | 59 | 01/02/13 |
Philip Broadley
BRD | Director/Board Member | 63 | 27/04/17 |
| Director/Board Member | 68 | 01/04/99 | |
Marc Dunoyer
PRN | Corporate Officer/Principal | 71 | 01/06/13 |
Andreas Rummelt
BRD | Director/Board Member | 66 | 01/08/21 |
Michel Demaré
CHM | Chairman | 67 | 01/09/19 |
Pascal Soriot
CEO | Chief Executive Officer | 64 | 01/10/12 |
Deborah DiSanzo
BRD | Director/Board Member | 64 | 01/12/17 |
Aradhana Sarin
DFI | Director of Finance/CFO | 50 | 01/08/21 |
Classe d'actions
| Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
|---|---|---|---|---|---|
| Action A | 1 | 1 550 235 025 | 1 497 890 686 ( 96,62 %) | 0 | 96,62 % |
Participations
| Nom | Actions | % | Valorisation |
|---|---|---|---|
| 18 750 000 | 75,00% | 1 200 298 875 $ | |
| 32 100 518 | 9,06% | 834 691 151 $ | |
| 108 923 023 | 37,58% | 677 619 929 $ | |
NIOX GROUP PLC 16,81% | 71 065 878 | 16,81% | 63 179 698 $ |
CELLECTIS S.A. 22,30% | 16 000 000 | 22,30% | 41 657 920 $ |
INNATE PHARMA 9,26% | 7 485 500 | 9,26% | 17 648 563 $ |
| 44 803 | 3,62% | 519 715 $ | |
| 884 956 | 1,99% | 57 522 $ |
Coordonnées société
AstraZeneca PLC
Cambridge Biomedical Campus 1 Francis Crick Avenue
CB2 0AA, Cambridge
+44 20 3749 5000
http://www.astrazeneca.co.uk
Sociétés du groupe
| Nom | Catégorie et Secteur |
|---|---|
R&Q Beta Co. Plc
 R&Q Beta Co. Plc Insurance Brokers/ServicesFinance R&Q Beta Co. Plc provides insurance services. The company was founded in 1994 and is headquartered in Cambridge, the United Kingdom. |
Insurance Brokers/Services
|
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. |
Miscellaneous Commercial Services
|
Alexion Pharmaceuticals, Inc. /New/
| |
Astrazeneca Finance & Holdings, Inc.
 Astrazeneca Finance & Holdings, Inc. Financial ConglomeratesFinance Part of AstraZeneca PLC, Astrazeneca Finance & Holdings, Inc. is an investment holding American company. The company is located in the US. |
Financial Conglomerates
|
AstraZeneca India Pvt Ltd.
 AstraZeneca India Pvt Ltd. Pharmaceuticals: MajorHealth Technology AstraZeneca India Pvt Ltd. operates as a biopharmaceutical company. The company was founded in 1979 and is headquartered in Bangalore, India. |
Pharmaceuticals: Major
|
Astrazeneca Treasury Ltd.
 Astrazeneca Treasury Ltd. Financial ConglomeratesFinance Part of AstraZeneca PLC, AstraZeneca Treasury Ltd. functions as an investment holding British company. The company is based in Cambridge, UK. |
Financial Conglomerates
|
Astrazeneca Holdings BV
| |
Astrazeneca Treasury BV
| |
AstraZeneca Employee Share Trust Ltd.
 AstraZeneca Employee Share Trust Ltd. Miscellaneous Commercial ServicesCommercial Services Part of AstraZeneca PLC, AstraZeneca Employee Share Trust Ltd. is a British company that provides business support services. The company is located in the UK. |
Miscellaneous Commercial Services
|
Secteur
Ventes par activité
Ventes par région
Révisions de BNA
| Varia. 1 janv. | Capi. | |
|---|---|---|
| +32,09% | 694 Md | |
| +29,39% | 593 Md | |
| -1,34% | 371 Md | |
| +20,34% | 331 Md | |
| +7,39% | 290 Md | |
| -3,03% | 209 Md | |
| +10,02% | 209 Md | |
| +8,49% | 169 Md | |
| -0,52% | 164 Md |
- Bourse
- Actions
- Action AZN
- Action ZEG
- Société AstraZeneca PLC
